Induction of differentiation and down-regulation of c-myb gene expression in ML-1 human myeloblastic leukemia cells by the clinically effective anti-leukemia agent meisoindigo

Biochemical Pharmacology

Volumn 51, Issue 11, 1996, Pages 1545-1551

  Liu, Xiao M ^a,b   Wang, Long G ^a,b   Li, Hong Y ^a   Ji, Xiu J ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

c myb expression; Cell differentiation; Chronic myeloid leukemia; Meisoindigo; ML 1 cells; New chemotherapeutic agent

Indexed keywords

ACID PHOSPHATASE; ANTILEUKEMIC AGENT; INDIRUBIN; TETRAZOLIUM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; DNA SYNTHESIS; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MYELOID LEUKEMIA; ONCOGENE C MYB; PHENOTYPE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INDOLES; LEUKEMIA, MYELOID; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYB; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0029948446     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00098-6     Document Type: Article

References (28)

1. Bloch A, Induced cell differentiation in cancer therapy. Cancer Treat Rep 68: 199-207, 1984.
2. Fujii Y, Takum T and Bloch A, A regulatory role for tumor necrosis factor (TNF) in ML-1 human myeloblastic leukemia cell maturation. Leuk Res 14: 941-947, 1990.
3. Diamond L, O'Brien TG and Rovera G, Tumor promoters: Effects on proliferation and differentiation of cells in culture. Life Sci 23: 1979-1988, 1978.
4. Hozumi M, Honma V, Tomida M, Okabe J, Kasukabe T, Sugiyama K, Hayashi M, Takenaga K and Yamamoto Y, Induction of differentiation of myeloid leukemia cells with various chemicals. Acta Haematol Jpn 42: 941-952, 1979.
5. Takeda K, Minowada J and Leasure JA, Comparison of the ability of various cytotoxic agents to induce the differentiation of human myeloblastic leukemia cells in vitro. Proc Am Assoc Cancer Res 23: 226, 1982.
6. Takeda K, Minowada J and Bloch A, Kinetics of appearance of differentiation-associated characteristics in ML-1, a line of human myeloblastic leukemia cells, after treatment with 12-O-tetradecanoylphorbol-13-acetate, dimethyl sulfoxide, or 1-β-D-arabinofuranosylcytosine. Cancer Res 42: 5152-5158, 1982.
7. Kuehl WM, Bender TP, Stafford J, McClinton D, Segal S and Dmitrovsky E, Expression and function of the c-myb oncogene during hematopoietic differentiation. Curr Top Microbiol Immunol 141: 317-323, 1988.
8. Watson RJ, Expression of the c-myb and c-myc genes is regulated independently in differentiating mouse erythroleukemia cells by common processes of premature transcription arrest and increased mRNA turnover. Mol Cell Biol 8: 3938-3942, 1988.
9. Mizuguchi G, Nakagoshi H, Nagase T, Nomura N, Date T, Ueno Y and Ishii S, DNA binding activity and transcriptional activator function of the human B-myb protein compared with c-MYB. J Biol Chem 265: 9280-9284, 1990.
10. Danish R, El-Awar O, Weber BL, Langmore J, Turka LA, Ryan JJ and Clarke MF, c-myb Effects on kinetic events during MEL cell differentiation. Oncogen 7: 901-907, 1992.
11. Craig RW and Bloch A, Early decline in c-myb oncogene expression in the differentiation of human myeloblastic leukemia (ML-1) cells induced with 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 44: 442-446, 1984.
12. Wang LG, Liu XM and Bloch A, Effect of growth and differentiation factors on oncogene expression in ML-1 human myeloblastic leukemia cells. Proc Am Assoc Cancer Res 34: A3103, 1993.
13. Han J, Traditional Chinese medicine and the search for new antineoplastic drugs. J Ethnopharmacol 24: 1-17, 1988.
14. Clinical Therapeutic Coordinating Group of Meisoindigo, Therapeutic effect of meisoindigo against chronic myeloid leukemia. Acta Haematol Sin 9: 135-139, 1988.
15. Liu XM, Wang LG and Ji XJ, Mechanism of meisoindigo on inhibitions of DNA and RNA biosynthesis in vitro. Chin J Pharmacol Toxicol 5: 204-208, 1991.
16. Ji XJ, Liu XM, Li K, Chen RH and Wang LG, Pharmacological studies of meisoindigo: Absorption and mechanism of action. Biomed Environ Sci 4: 332-337, 1991.
17. Honma Y, Honma C and Bloch A, Mechanism of interaction between antineoplastic agents and natural differentiation factors in the induction of human leukemic cell maturation. Cancer Res 46: 6311-6315, 1986.
18. Sakagami H, Hromchak R and Bloch A, Prevention of phorbol ester receptor down modulation in human myeloblastic leukemia ML-1 cells by differentiation-stimulating serum components. Cancer Res 44: 3330-3335, 1984.
19. Takuma T, Takeda K and Konno K, Synergism of tumor necrosis factor and interferon-γ in induction of differentiation of human myeloblastic leukemic ML-1 cells. Biochem Biophys Res Commun 145: 514-521, 1987.
20. Chomczynski P and Nacchi N, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
21. Sariban E, Mitchell T and Kufe D, Expression of the c-fms proto-oncogene during human monocytic differentiation. Nature 316: 64-66, 1985.
22. Sachs L, The differentiation of myeloid leukemia cells: New possibilities for therapy. Br J Haematol 40: 501-517, 1978.
23. Hozumi M, Fundamentals of chemotherapy of myeloid leukemia cell differentiation. Adv Cancer Res 38: 121-169, 1983.
24. Sartorelli AC, Malignant cell differentiation as a potential therapeutic approach. Br J Cancer 52: 293-302, 1985.
25. Wang LG, Liu XM, Li ZR, Denstman S and Bloch A, Differential binding of nuclear c-ets-1 protein to an intro 1 fragment of the c-myb gene in growth versus differentiation. Cell Growth Differ 5: 1243-1251, 1994.
26. Clarke MF, Kukowska Latallo JK, Westin E, Smith M and Prochownik EV, Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol Cell Biol 8: 884-892, 1988.
27. Todokoro K, Watson RJ, Higo H, Amanuma H, Kuramochi S, Yanagisawa H and Ikawa Y, Down regulation of c-myb gene expression is a prerequisite for erythropoietin-induced erythroid differentiation. Proc Natl Acad Sci USA 85: 8900-8904, 1988.
28. Miller WH Jr, Moy D, Li A, Grippo JF and Dmitrovsky E, Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line. Oncogene 5: 511-517, 1990.